Appendix 2 - Public Hearings

Appendix 2Public Hearings

Wednesday, 31 January 2024

Corinthian Room, Sydney Masonic Centre

66 Goulburn St

Sydney

Cancer Council Australia

Ms Megan Varlow, Director, Cancer Control Policy

Rare Cancers Australia

Ms Christine Cockburn, Chief Executive Officer

Head and Neck Cancer Australia

Ms Nadia Rosin, Chief Executive Officer

Ms Carolyn Smith, Board Director

Mr Matthew Magarey, Board Director

Neuroblastoma Australia

Ms Lucy Jones, Chief Executive Officer

Leukaemia Foundation

Mr Tim Murphy, General Manager, Blood Cancer Partnerships

Mrs Julia Sammut, Private capacity

Cancer Assistance Network

Mrs Emma Phillips, Executive Director

Ms Majella Gallagher, Advocacy and External Relations

Australian Cancer Atlas

Dr Kerrie Mengersen, Distinguished Professor, Centre for Data Science, Queensland University of Technology

Dr Peter Baade, Senior Manager, Descriptive Epidemiology, Cancer Council Queensland

Private Cancer Physicians of Australia

Associate Professor Christopher Steer, President

Professor Matthew Dun, Professor of Paediatric Haematology and Oncology Research, Founder and Director of RUN DIPG

Australian DIPG families

Mrs Beau Kemp

Mrs Hannah Pringle

Ms Angie Sari-Daher

Kate, Private capacity

Michelle, Private capacity

Children’s Cancer Institute

Dr Peter Wejbora, Director Research Development and Partnerships

Dr Emily Mould, Head of Business Development

Ms Anastasia Glushko, Stakeholder Engagement Manager

Sydney Children’s Hospitals Network

Dr Richard Mitchell, Director, Kids Cancer Centre, Sydney Childrens Hospital Randwick

Dr Luciano Dalla-Pozza, Senior Staff Specialist and Director, Cancer Centre for Children, The Childrens Hospital at Westmead

Associate Professor Antoinette Anazodo, Paediatric and Adolescent Oncologist, Sydney Childrens Hospital Randwick

Clinical Oncology Society of Australia

Dr David Chan, Chair, Neuroendocrine Tumours Group

The Daffodil Centre

Professor Karen Veronica Canfell, Director

The Daffodil Centre and the University of Sydney Cancer Research Network

Professor Stephen Clarke

University of Sydney Cancer Research Network

Professor Anna Defazio, Convenor

Associate Professor Kathy Tucker, Private capacity

IQVIA

Mr Andrew Sutton, Vice President and General Manger

Mr Quentin Bracquart, Head of Payer, Provider and Government Services and Principal, Strategic Insights and Analytics

Roche

Mr Ben Robinson, Head, Access and Innovation

Dr Richard Woodfield, Country Medical Director

AstraZeneca

Ms Penny George, Director of Corporate Affairs

Ms Rachael Anderson, Market Access Director

Thursday, 1 February 2024

Edinburgh Room, Stamford Plaza Melbourne

111 Little Collins St

Melbourne

NeuroEndocrine Cancer Australia

Ms Meredith Cummins, Chief Executive Officer

Professor Rodney Hicks, Honorary Board Member

Peter MacCallum Cancer Centre

Associate Professor Grace Kong, Medical Consultant, Nuclear Medicine Physician and Co-Chair, Neuroendocrine Tumour Unit

Mrs Kate Wakelin, Neuroendocrine Tumour Clinical Nurse Consultant

Associate Professor Benjamin Loveday, Surgical Oncologist

Mrs Susanne Manks, Patient

Lymphoma Australia

Ms Sharon Winton, Chief Executive Officer

Australasian Leukaemia and Lymphoma Group

Ms Delaine Smith, Chief Executive Officer

Rotary Outreach Myeloma Program

Mr Peter Allen OAM, Secretary

Mrs Patricia Marjorie O'Hara OAM, Committee Member

Australian Genomics

Mrs Tiffany Boughtwood, Managing Director

Dr Jane Tiller, Ethical, Legal and Social Adviser, Public Health Genomics, Monash University

Professor Paul Lacaze, Head of Public Health Genomics, School of Public Health and Preventative Medicine, Monash University

Emily, Private capacity

Jelena, Private capacity

Katherine, Private capacity

Kristina, Private capacity

Michael, Private capacity

Caitlin, Private capacity

Cancer Trials Australia

Dr Kurt Lackovic, Chief Executive Officer

Professor Clare Scott, Board Member

TrialHub

Ms Anne Woollett, Director

Dr Chloe Georgiou, Chair, Victorian Rare Cancer, Clinical Trial Alliance

Professor Clare Scott, Co-Chair, Victorian Rare Cancer, Clinical Trial Alliance

Victorian Cancer Biobank

Dr Wayne Ng, General Manager

Royal Australian College of General Practitioners

Professor Mark Morgan, Chair, Expert Committee for Quality Care

Society of Hospital Pharmacists of Australia

Mr Jerry Yik, Head, Policy and Advocacy

Mr Shaun O'Connor, Co-Chair, Oncology and Haematology Leadership Committee

Ovarian Cancer Australia

Associate Professor Anna Boltong, Chief Executive Officer

Mrs Bridget Bradhurst, Acting Chief of Support and Advocacy

Ms Claire MacDonald, Governance Manager

Pancare Foundation

Mr Doug Hawkins, Chief Executive Officer

Mr David Menzies, Head of PanSupport

Omico

Professor David Thomas, Chief Executive Officer

Bristol-Myers Squibb Australia

Mr Owen Smith, Managing Director

Ipsen

Mr Julien Dagher, General Manager Australia & New Zealand

Mr Simon Higgins, Director, Public Affairs and Market Access

Tuesday, 20 February 2024

Centurion 1, Crowne Plaza Hobart

110 Liverpool St

Hobart

Menzies Institute for Medical Research, University of Tasmania

Professor Joanne Dickinson, Lead, Cancer Genetics

Royal Hobart Hospital

Dr Thomas (Tom) Walwyn, Staff Specialist, Paediatric, Adolescent and Young Adult Oncology

Dr Anna Johnston, Director of Clinical Haematology

Dr Melanie (Mel) Wuttke, Head of Medical Oncology

Glen, Private capacity

Jacqui, Private capacity

Jenaya, Private capacity

Judi, Private capacity

Lesley, Private capacity

Peter, Private capacity

Robert, Private capacity

Friday, 1 March 2024

Committee Room 1S3, Parliament House

Parliament Dr

Canberra

ZERO Childhood Cancer Program

Associate Professor Vanessa Tyrrell, Director

Ms Anastasia Glushko, Stakeholder Engagement Manager, Children’s Cancer Institute

Professor Nick Gottardo, Head, Department of Paediatric Oncology and Haematology, Perth Children's Hospital; and Chair, Australian and New Zealand Children's Haematology and Oncology Group

Australian Teletrial Program

Ms Kaye Hewson, Director, Australian Teletrial Program, National Office, Queensland Health

Dr Julie White, Executive Director, Office of Research and Innovation

Dr Wei-Sen Lam, Medical Lead, Teletrials, WA Country Health Service

Canberra Health Services

Ms Clare Crawford, Senior Director, Revenue and Hospital Financial Services

Mrs Florence Young, Executive Branch Manager and Deputy Chief Financial Officer

National Rural Health Alliance

Ms Clare Fitzmaurice, Policy and Data Analytics Officer

Ms Margaret Deerain, Director of Policy and Strategy Development

Dr Ian Kamerman, Secretary, Rural Doctors Association NSW

Cancer Australia

Professor Dorothy Keefe, Chief Executive Officer

Ms Claire Howlett, Deputy Chief Executive Officer

Department of Health and Aged Care

Ms Adriana Platona, First Assistant Secretary, Technology Assessment and Access Division

Ms Renaye Lucchese, Assistant Secretary, Genomics and Health

Mrs Ariane Hermann, Acting First Assistant Secretary

Dr Masha Somi, Assistant Secretary, Health and Medical Research Office

Ms Natasha Ploenges, Chief Executive Officer, Health and Medical Research Office

National Health and Medical Research Council

Dr Nicholas Johnson, Executive Director, Research Partnerships Branch

Dr Julie Glover, Research Foundations Branch

Tuesday, 9 April 2024

Banqueting Room, Adelaide Town Hall

Adelaide

Cancer Council South Australia

Dr Peter Diamond, General Manager Support and Research

Mrs Amanda Robertson, Information and Support Manager

Mrs Miriam Cocking, Private capacity

Angel Flight Australia

Mr Howard Hobbs, Chair

Royal Adelaide Hospital

Professor Hamish Scott, Head of Department, Genetics and Molecular Pathology, SA Pathology

Dr Anna Brown, Head, Molecular Oncology, SA Pathology

The Hospital Research Foundation Group

Mr Paul Flynn, Group Chief Executive Officer

Associate Professor Gabby Cehic AM, Clinical Lead, South Australian Peptide Receptor Radionuclide Therapy Service, and Chair, South Australian Gastroenteropancreatic Neuroendocrine Tumours Multidisciplinary Team, South Australia Medical Imaging

Dr Sally Cox, Private capacity